Spots Global Cancer Trial Database for hereditary breast and ovarian cancer syndrome
Every month we try and update this database with for hereditary breast and ovarian cancer syndrome cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Protexa® Versus TiLoopBra® in Immediate Breast Reconstruction- A Pilot Study | NCT02562170 | Breast Cancer Hereditary Brea... | TiLoop Bra Protexa | 18 Years - 75 Years | Medical University of Vienna | |
| Telemedicine vs. Face-to-Face Cancer Genetic Counseling | NCT00609505 | Hereditary Brea... Lynch Syndrome | Telemedicine Face-to-Face | 18 Years - | Duke University | |
| Risk-Reducing Surgeries for Hereditary Ovarian Cancer | NCT03294343 | Hereditary Brea... Colorectal Neop... Ovariectomy Hysterectomy | salpingo-oophor... salpingo-oophor... Follow-up | 35 Years - | Peking Union Medical College Hospital | |
| A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer | NCT02203513 | Ovarian Cancer Breast Cancer Prostate Cancer | LY2606368 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer | NCT02203513 | Ovarian Cancer Breast Cancer Prostate Cancer | LY2606368 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention | NCT05677048 | Gynecologic Can... Ovary Cancer Pancreatic Canc... Breast Cancer Lynch Syndrome Hereditary Brea... Colon Cancer Endometrial Can... Uterus Cancer | Free genetic te... IGNITE-TX Group IGNITE-TX and f... | 18 Years - | M.D. Anderson Cancer Center | |
| Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199 | NCT01445275 | Fallopian Tube ... Hereditary Brea... Ovarian Carcino... Primary Periton... | Evaluation of C... Medical Chart R... Study of Socioe... | 30 Years - | GOG Foundation | |
| Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199 | NCT01445275 | Fallopian Tube ... Hereditary Brea... Ovarian Carcino... Primary Periton... | Evaluation of C... Medical Chart R... Study of Socioe... | 30 Years - | GOG Foundation | |
| Enhance the Use of Genetic Counseling and Testing in Latinas | NCT04544501 | Hereditary Brea... | Culturally-Targ... FORCE Fact Shee... | 18 Years - | Georgetown University | |
| Risk-Reducing Surgeries for Hereditary Ovarian Cancer | NCT03294343 | Hereditary Brea... Colorectal Neop... Ovariectomy Hysterectomy | salpingo-oophor... salpingo-oophor... Follow-up | 35 Years - | Peking Union Medical College Hospital | |
| Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations | NCT02760849 | Deleterious BAR... Deleterious BRC... Deleterious BRC... Deleterious BRI... Deleterious EPC... Deleterious MLH... Deleterious MSH... Deleterious MSH... Deleterious PAL... Deleterious PMS... Deleterious RAD... Deleterious RAD... Hereditary Brea... Premenopausal | Laboratory Biom... Oophorectomy Quality-of-Life... Salpingectomy Salpingo-Oophor... | 30 Years - 50 Years | M.D. Anderson Cancer Center | |
| Inherited Susceptible Genes Among Epithelial Ovarian Cancer | NCT03015376 | Ovarian Neoplas... Hereditary Brea... | - | Peking Union Medical College Hospital | ||
| Tissue Expansion in Breast Reconstruction Without Drains | NCT03784859 | Breast Cancer Hereditary Brea... Breast Implant;... | Insertion of Ti... | 21 Years - | Cedars-Sinai Medical Center | |
| Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations | NCT02760849 | Deleterious BAR... Deleterious BRC... Deleterious BRC... Deleterious BRI... Deleterious EPC... Deleterious MLH... Deleterious MSH... Deleterious MSH... Deleterious PAL... Deleterious PMS... Deleterious RAD... Deleterious RAD... Hereditary Brea... Premenopausal | Laboratory Biom... Oophorectomy Quality-of-Life... Salpingectomy Salpingo-Oophor... | 30 Years - 50 Years | M.D. Anderson Cancer Center | |
| Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer | NCT00535119 | Adult Solid Neo... BRCA1 Mutation ... BRCA2 Mutation ... Hereditary Brea... | Carboplatin Laboratory Biom... Paclitaxel Pharmacological... Veliparib | 18 Years - | National Cancer Institute (NCI) | |
| Attitudes About Childbearing And Fertility With Inherited Breast And Ovarian Cancer Syndromes (HBOC) | NCT00829959 | Breast Cancer Ovarian Cancer | Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| Pediatric Reporting of Adult-Onset Genomic Results | NCT03832985 | Hereditary Brea... Lynch Syndrome Familial Hyperc... | Receive an adul... Receive a pedia... Control - No Re... | - | Geisinger Clinic | |
| Enhance the Use of Genetic Counseling and Testing in Latinas | NCT04544501 | Hereditary Brea... | Culturally-Targ... FORCE Fact Shee... | 18 Years - | Georgetown University | |
| Direct Information to At-risk Relatives | NCT04197856 | Familial Breast... Familial Colore... Hereditary Brea... Hereditary Brea... Lynch Syndrome | Standard care e... Offer of health... | 18 Years - | Umeå University | |
| Women at Risk of Breast Cancer and OLFM4 | NCT02653105 | Hereditary Brea... | OLFM4 | 18 Years - | Institut Cancerologie de l'Ouest | |
| Protexa® Versus TiLoopBra® in Immediate Breast Reconstruction- A Pilot Study | NCT02562170 | Breast Cancer Hereditary Brea... | TiLoop Bra Protexa | 18 Years - 75 Years | Medical University of Vienna | |
| Search Allelic Imbalance of Expression of BRCA Genes in Hereditary Risk of Breast and/or Ovarian Cancer | NCT01333748 | Hereditary Brea... | blood collectio... blood collectio... | 18 Years - | Centre Francois Baclesse |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
